Pinsky, Michael R.
Bedoya, Armando
Bihorac, Azra
Celi, Leo
Churpek, Matthew
Economou-Zavlanos, Nicoleta J.
Elbers, Paul
Saria, Suchi
Liu, Vincent
Lyons, Patrick G.
Shickel, Benjamin
Toral, Patrick
Tscholl, David
Clermont, Gilles
Funding for this research was provided by:
National Institutes of Health (HL141916)
National Institutes of Health,United States (NR013912)
Article History
Received: 22 February 2024
Accepted: 5 March 2024
First Online: 8 April 2024
Declarations
:
: Michael R. Pinsky, MD CM: Named inventor of a University of Pittsburgh owned US patent (#7,678,057): “Device and system that identifies cardiovascular insufficiency.” He is also an Editor of the journal Critical Care.Armando Bedoya, PhD: No conflicts.Azra Bihorac, MD: No conflicts.Leo Celi, MD: No conflicts.Matthew Churpek, MD, MPH, PhD: named inventor on a U.S. patent (#11,410,777) for “eCART” and receive royalties from the University of Chicago for this intellectual property.Nicoleta Economou-Zavlanos, PhD: No conflicts.Paul Elbers, MD PhD Amsterdam UMC is entitled to royalties from Pacmed BV Suchi Saria PhD: No conflicts.Vincent Liu, MD: No conflicts.Patrick G. Lyons, MD, MSc: No conflicts.Benjamin Shickel, PhD: No conflicts.Patrick Toral, MD Amsterdam UMC is entitled to royalties from Pacmed BV David Tscholl MD has received grants, research funding, or honoraria from Koninklijke Philips N.V., Amsterdam, The Netherlands; Instrumentation Laboratory—Werfen, Bedford, MA. Swiss Foundation for Anaesthesia Research, Zurich, Switzerland; and the International Symposium on Intensive Care and Emergency Medicine Brussels, Belgium. Gilles Clermont, MD is Chief Medical Officer of NOMA AI, Inc. No conflict.